×

Prevention and treatment of amyloidogenic disease

  • US 8,535,673 B2
  • Filed: 08/20/2004
  • Issued: 09/17/2013
  • Est. Priority Date: 12/02/1997
  • Status: Expired due to Fees
First Claim
Patent Images

1. A humanized antibody that specifically binds an epitope contained within positions 13-28 of Aβ

  • , wherein the antibody is a humanized version of monoclonal antibody 266 (ATCC accession number PTA-6123).

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×